Expression and significance of F0XP1, HIF-la and VEGF in renal clear cell carcinoma

Journal of B.U.ON.

Volumn 20, Issue 1, 2015, Pages 188-195

  Li, Wan ^a   Huang, Jingyong ^a   Chen, Jianou ^b   Wang, Rongrong ^a   Dong, Chunge ^c   Lu, Shanshan ^a   Wu, Xiuling ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b Wenzhou Hospital of Traditional Chinese Medicine   (China)

^c First Hospital of Wenling   (China)

Author keywords

Clear cell renal cell carcinomafarkhead transcription factor 1; Hypoxia inducible factor 1; Vascular endothelial growth factor

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP1; UNCLASSIFIED DRUG; VASCULOTROPIN; FORKHEAD TRANSCRIPTION FACTOR; FOXP1 PROTEIN, HUMAN; HIF1A PROTEIN, HUMAN; REPRESSOR PROTEIN; TUMOR MARKER; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ANOREXIA; ARTICLE; CANCER GRADING; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL MEMBRANE; CELL NUCLEUS; CLEAR CELL CARCINOMA; CYTOPLASM; FEMALE; FOLLOW UP; HEMATURIA; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY DISTAL TUBULE; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; LOW BACK PAIN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RENAL CLEAR CELL CARCINOMA; RNA EXTRACTION; WEIGHT REDUCTION; CHEMISTRY; COMPARATIVE STUDY; GENETICS; KIDNEY TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; SECONDARY; TIME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; REPRESSOR PROTEINS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84928696206     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 2013;499:43-49.
2. Rathmell WK, Chen S. VHL inactivation in renal cell carcinoma: implications for diagnosis, prognosis and treatment. Expert Rev Anticancer Ther 2008;8:63-73.
3. Shen C, Kaelin WG Jr. The VHL/HIF axis in clear cell renal carcinoma. Semin Cancer Biol 2013;23:18-25.
4. Arjumand W, Sultana S. Role of VHL gene mutation in human renal cell carcinoma. Tumour Biol 2012;33:9- 16.
5. Banham AH, Beasley N, Campo E et al. The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p. Cancer Res 2001;61:8820-8829.
6. Hoeller S, Schneider A, Haralambieva E, Dirnhofer S, Tzankov A. FOXP1 protein overexpression is associated with inferior outcome in nodal diffuse large B-cell lymphomas with non-germinal centre phenotype, independent of gains and structural aberrations at 3pl4. 1. Histopathology 2010;57:73-80.
7. Streubel B, Vinatzer U, Lamprecht A, Raderer M, Chott A. T (3; 14)(pl4. 1; q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia 2005;19:652-658.
8. Ijichi N, Ikeda K, Horie-Inoue K, Inoue S. FOXP1 and Estrogen Signaling in Breast Cancer. Vitam Horm 2013;93:203-212.
9. Banham AH, Boddy J, Launchbury R et al. Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia. The Prostate 2007;67:1091-1098.
10. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6:655-663.
11. Lidgren A, Hedberg Y, Grankvist K, Rasmuson T, Bergh A, Ljungberg B Hypoxia-inducible factor la expression in renal cell carcinoma analyzed by tissue microarray. Eur Urol 2006;50:1272-1277.
12. Toma MI, Weber T, Meinhardt M et al. Expression of the Forkhead transcription factor FOXP1 is associated with tumor grade and Ki67 expression in clear cell renal cell carcinoma. Cancer Invest 2011;29:123-129.
13. Carroll VA, Ashcroft M. Role of hypoxia-inducible factor (HIF)-lalpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway. Cancer Res 2006;66:6264-6270.
14. Klatte T, Seligson DB, Riggs SB et al. Hypoxia-Inducible Factor 1A in Clear Cell Renal Cell Carcinoma. Clin Cancer Res 2007;13:7388-7393.
15. Agani F, Jiang BH. Oxygen-independent regulation of HIF-1: novel involvement of PI3K/AKT/mTORpathway in cancer. Curr Cancer Drug Targets 2013;13:245- 251.
16. Stitt TN, Drujan D, Clarke BA et al. The IGF-1/PI3K/Akt pathway prevents expression of muscle atro-phy- induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 2004;14:395-403.
17. Giatromanolaki A, Koukourakis MI, Sivridis E, Gatter KC, Harris AL, Banham AH. Loss of expression and nuclear/cytoplasmic localization of the FOXP1 fork- head transcription factor are common events in early endometrial cancer: relationship with estrogen receptors and HIF-la expression. Mod Pathol 2006;19:9-16.